The role of resistin in the genesis of metabolic disorders in pathological pregnancy

Pathological gestational weight gain (GWG) is a risk factor for obstetric and perinatal complications. High metabolic activity of adipose tissue and the placenta during pregnancy manifests as an increased production of adipokines that are involved in glucose regulation and insulin sensitivity. The a...

Full description

Bibliographic Details
Main Author: S. O. Ostafiichuk
Format: Article
Language:English
Published: National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2019-10-01
Series:The Ukrainian Biochemical Journal
Subjects:
Online Access:http://ukrbiochemjournal.org/wp-content/uploads/2019/09/Ostafiichuk_5_19.pdf
_version_ 1797422207522045952
author S. O. Ostafiichuk
author_facet S. O. Ostafiichuk
author_sort S. O. Ostafiichuk
collection DOAJ
description Pathological gestational weight gain (GWG) is a risk factor for obstetric and perinatal complications. High metabolic activity of adipose tissue and the placenta during pregnancy manifests as an increased production of adipokines that are involved in glucose regulation and insulin sensitivity. The aim of this study was to determine the role of resistin in the genesis of metabolic disorders in pathological GWG pregnancies. The 163 pregnant women were examined in the study: 97 (59.5%) had normal, 18 (11.0%) had insufficient and 48 (29.4%) had excessive prepregnancy weight and obesity. GWG was the recommended level in 56 (34.4%), insufficient in 33 (20.2%), and excessive in 74 (45.4%) women. Anthropometry was performed in each trimester of pregnancy, the weight gain was measured, and the percentage of body fat mass, concentrations of resistin, glucose, insulin, and the HOMA-IR were evaluated. Positive associations were found between hyperresis­tinemia in the second trimester of pregnancy, and subsequent weight gain (r = 0.27, P = 0.0006), percentage of body fat mass (r = 0.93, P = 0.000) and insulin resistance (r = 0.89, P = 0.000) in late pregnancy; these associations were especially evident in excessive GWG. Determination of predictors of insulin resistance, associated with endocrine activity of adipose tissue, such as the adipokine resistin, in the second trimester of pregnancy may help to predict the severity of metabolic shifts during pregnancy and the risk of developing obstetric and perinatal complications.
first_indexed 2024-03-09T07:29:52Z
format Article
id doaj.art-121fd40d627b4b8dac9ab2dca7785e28
institution Directory Open Access Journal
issn 2409-4943
2413-5003
language English
last_indexed 2024-03-09T07:29:52Z
publishDate 2019-10-01
publisher National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry
record_format Article
series The Ukrainian Biochemical Journal
spelling doaj.art-121fd40d627b4b8dac9ab2dca7785e282023-12-03T06:27:18ZengNational Academy of Sciences of Ukraine, Palladin Institute of BiochemistryThe Ukrainian Biochemical Journal2409-49432413-50032019-10-01915556210.15407/ubj91.05.055The role of resistin in the genesis of metabolic disorders in pathological pregnancyS. O. Ostafiichuk0Ivano-Frankivsk National Medical University, UkrainePathological gestational weight gain (GWG) is a risk factor for obstetric and perinatal complications. High metabolic activity of adipose tissue and the placenta during pregnancy manifests as an increased production of adipokines that are involved in glucose regulation and insulin sensitivity. The aim of this study was to determine the role of resistin in the genesis of metabolic disorders in pathological GWG pregnancies. The 163 pregnant women were examined in the study: 97 (59.5%) had normal, 18 (11.0%) had insufficient and 48 (29.4%) had excessive prepregnancy weight and obesity. GWG was the recommended level in 56 (34.4%), insufficient in 33 (20.2%), and excessive in 74 (45.4%) women. Anthropometry was performed in each trimester of pregnancy, the weight gain was measured, and the percentage of body fat mass, concentrations of resistin, glucose, insulin, and the HOMA-IR were evaluated. Positive associations were found between hyperresis­tinemia in the second trimester of pregnancy, and subsequent weight gain (r = 0.27, P = 0.0006), percentage of body fat mass (r = 0.93, P = 0.000) and insulin resistance (r = 0.89, P = 0.000) in late pregnancy; these associations were especially evident in excessive GWG. Determination of predictors of insulin resistance, associated with endocrine activity of adipose tissue, such as the adipokine resistin, in the second trimester of pregnancy may help to predict the severity of metabolic shifts during pregnancy and the risk of developing obstetric and perinatal complications.http://ukrbiochemjournal.org/wp-content/uploads/2019/09/Ostafiichuk_5_19.pdfgestational weight gainglucoseinsulin resistanceresistin
spellingShingle S. O. Ostafiichuk
The role of resistin in the genesis of metabolic disorders in pathological pregnancy
The Ukrainian Biochemical Journal
gestational weight gain
glucose
insulin resistance
resistin
title The role of resistin in the genesis of metabolic disorders in pathological pregnancy
title_full The role of resistin in the genesis of metabolic disorders in pathological pregnancy
title_fullStr The role of resistin in the genesis of metabolic disorders in pathological pregnancy
title_full_unstemmed The role of resistin in the genesis of metabolic disorders in pathological pregnancy
title_short The role of resistin in the genesis of metabolic disorders in pathological pregnancy
title_sort role of resistin in the genesis of metabolic disorders in pathological pregnancy
topic gestational weight gain
glucose
insulin resistance
resistin
url http://ukrbiochemjournal.org/wp-content/uploads/2019/09/Ostafiichuk_5_19.pdf
work_keys_str_mv AT soostafiichuk theroleofresistininthegenesisofmetabolicdisordersinpathologicalpregnancy
AT soostafiichuk roleofresistininthegenesisofmetabolicdisordersinpathologicalpregnancy